首页> 外国专利> ONCE-A-DAY ORAL ADMINISTRATION SUSTAINED-RELEASE FORMULATION COMPRISING ITOPRIDE HYDROCHLORIDE

ONCE-A-DAY ORAL ADMINISTRATION SUSTAINED-RELEASE FORMULATION COMPRISING ITOPRIDE HYDROCHLORIDE

机译:含盐酸碘化物的每日一次口服给药缓释制剂

摘要

An oral administration sustained-release two-layer tablet comprising itopride hydrochloride of the present invention, to satisfy both rapid pharmacological activity expression and sustained pharmacological activity for 24 hours, comprises: a quick-release layer which enables the drug to be dissolved in a rapid manner; and a sustained-release layer which enables the drug to be dissolved in a sustained manner. To exhibit an optimal release, hydroxypropyl methylcellulose having dissolution control properties depending on a certain degree of substitution and viscosity is used as a release regulator. The dissolution rate in gastrointestinal tracts with differing pH and residence time in gastrointestinal tracts are controlled. In addition, in the present invention, provided is a method for manufacturing an oral administration sustained-release two-layer tablet comprising itopride hydrochloride which is designed to increase patients adaptation to medication, prevent side effects caused by excessive release of early phase active ingredients, and maintain a constant dissolution rate.;COPYRIGHT KIPO 2019
机译:为了同时满足24小时的快速药理活性表达和持续的药理活性,包含本发明的盐酸伊托必利的口服缓释两层片剂包括:速释层,其使药物能够快速溶解。方式;缓释层使药物能够持续溶解。为了表现出最佳的释放,具有取决于一定程度的取代度和粘度的溶解控制特性的羟丙基甲基纤维素被用作释放调节剂。控制pH值和在胃肠道中停留时间不同的胃肠道中的溶出速率。另外,在本发明中,提供了一种制备包含盐酸伊托必利的口服给药缓释两层片剂的方法,该片剂旨在增加患者对药物的适应性,防止由早期活性成分的过量释放引起的副作用,并保持恒定的溶出度。; COPYRIGHT KIPO 2019

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号